Continuing proactive engagement with the nation’s governors and state executive teams that has remained a priority throughout the pandemic, NACDS this week urged states to take actions that will help ensure patients have ready access to vaccines from their trusted pharmacies and pharmacists.
National pharmacy group with 40,000 traditional, supermarket and mass retail pharmacies and 155,000 pharmacists: today’s announcement further empowers the paramount education, trust and accessibility of pharmacies and pharmacists – the face of neighborhood healthcare.
NACDS says using discount-card drug prices in tally of “usual and customary” pharmacy charges is not lawful, wrongly depresses payments to pharmacies, and ultimately could harm patients: "For consumers on tight budgets who rely on third-party discount cards to pay for their medications, the potential loss of access to these discounted medications would be devastating.”
Patient groups urging action in next COVID bill represent 200 million Americans living with cancer, cardiovascular disease, HIV, mental health issues, liver disease, lupus and other conditions.
National organization representing pharmacies of diverse formats and sizes says: “By any measure, America’s pharmacies present patients and the nation with an efficient, effective and essential component of vaccine deployment”
The discussion addressed the question: “Once the COVID-19 vaccine is available, how do we immunize the American people the fastest way possible so we can open all aspects of the U.S. economy?”
Article extends collaborations between NACDS and University of Pittsburgh, cites pharmacy’s ability to provide preventive services and chronic care management.
Letter to National Governors Association leaders and all governors stresses the importance of establishing certainty that flexibilities established early in the pandemic will be sustained.
Five faculty members from pharmacy schools and colleges nationwide have been selected to participate in the 18-month research mentorship program.
NACDS issues an open letter to Congress urging a necessary step to help scale and sustain COVID-19 testing.
